These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16497339)

  • 21. Development of therapeutics: opportunities within complementary and alternative medicine.
    Engel LW; Straus SE
    Nat Rev Drug Discov; 2002 Mar; 1(3):229-37. PubMed ID: 12120507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series.
    Brown AC
    Food Chem Toxicol; 2017 Sep; 107(Pt A):449-471. PubMed ID: 27818322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional supplements and the EU: is anyone happy?
    Eberhardie C
    Proc Nutr Soc; 2007 Nov; 66(4):508-11. PubMed ID: 17961271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicians' understanding of the regulation of dietary supplements.
    Ashar BH; Rice TN; Sisson SD
    Arch Intern Med; 2007 May; 167(9):966-9. PubMed ID: 17502539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and regulation of natural products used as foods and food ingredients.
    Abdel-Rahman A; Anyangwe N; Carlacci L; Casper S; Danam RP; Enongene E; Erives G; Fabricant D; Gudi R; Hilmas CJ; Hines F; Howard P; Levy D; Lin Y; Moore RJ; Pfeiler E; Thurmond TS; Turujman S; Walker NJ
    Toxicol Sci; 2011 Oct; 123(2):333-48. PubMed ID: 21821733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary supplement Standard Reference Materials.
    Sander LC; Sharpless KE; Wise SA
    Life Sci; 2006 Mar; 78(18):2044-8. PubMed ID: 16457853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro drug interaction potential of dietary supplements containing multiple herbal components.
    Foti RS; Wahlstrom JL; Wienkers LC
    Drug Metab Dispos; 2007 Feb; 35(2):185-8. PubMed ID: 17093003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body; partial stay of compliance. Food and Drug Administration, HHS. Final rule; partial stay of compliance.
    Fed Regist; 2000 Sep; 65(190):58346-50. PubMed ID: 11503646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act.
    Foote JC
    J Allied Health; 2007; 36(1):57-60. PubMed ID: 17425193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herbal products and dietary supplements: a survey of use, attitudes, and knowledge among older adults.
    Marinac JS; Buchinger CL; Godfrey LA; Wooten JM; Sun C; Willsie SK
    J Am Osteopath Assoc; 2007 Jan; 107(1):13-20; quiz 21-3. PubMed ID: 17299031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
    Kantor M
    J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
    Dodge T; Kaufman A
    Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.
    Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
    J Pain Palliat Care Pharmacother; 2004; 18(3):95-107. PubMed ID: 15364637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
    McNamara SH
    Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
    [No Abstract]   [Full Text] [Related]  

  • 38. Alternative medicine--the case of herbal remedies.
    Oz M; Rose E; Lemole GM
    N Engl J Med; 1999 Feb; 340(7):564-5; author reply 566. PubMed ID: 10026041
    [No Abstract]   [Full Text] [Related]  

  • 39. Complementary and alternative medicine: risks and special considerations in pretransplant and posttransplant patients.
    Corey RL; Rakela J
    Nutr Clin Pract; 2014 Jun; 29(3):322-31. PubMed ID: 24710858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bringing evidence to complementary and alternative medicine in children with cancer: Focus on nutrition-related therapies.
    Kelly KM
    Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):490-3; discussion 498. PubMed ID: 18064645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.